Cialis Marketing Plan
-
Upload
asaad-bayan -
Category
Documents
-
view
223 -
download
1
Transcript of Cialis Marketing Plan
7/31/2019 Cialis Marketing Plan
http://slidepdf.com/reader/full/cialis-marketing-plan 1/5
Cialis Marketing Plan
4 / 1 1 / 2 0 1 2
Bakr El Allali - 341654
Michiel Mak - 345098
Asaad Dan Bayan – 343160
Léopold Bailby - 343603
7/31/2019 Cialis Marketing Plan
http://slidepdf.com/reader/full/cialis-marketing-plan 2/5
Cialis is a new product from the joint venture of ICOS and Eli Lilly that helps people who are suffering
from erectile dysfunction. However this product has to go in a market where Viagra is already an
established name for ED sufferers and Levitra, a new drug ED drug. Cialis’ launch is very important for
both the companies in the joint venture and everything must be done with care to assure its success.
Market Segmentation
Considering ED is the main cause for patients to use Cialis, it is important to see that age plays a very
significant role. For example at the ages of 20-39, less the 10% of the people had ED, while for
respondents of 60+ the chances of ED were between ~40%-60. A gradual increase is observed as age
increases. Thus it is evident that the market should be segmented by age. As people get older, they are
more likely to suffer from ED and thus become the target market for Cialis. Another important feature of
people who were patients of ED is that over 80% of them had a sexual partner. The sexual partner was
also the main cause for seeking ED treatment with an average of 43% over six countries. And 70% of the
patients were married, thus it can be a target segment for the product. Thus, people with a sexual partner
are another market segment for Cialis. Geographic distribution is also an important segmentation of the
market. The United States of America are by far the highest source of income for Viagra. Considering
Viagra was the main ED drug, their market is almost the same as Cialis’ market. It is to be noted that the
family doctors and urologists were the main sources for getting ED treatment. They should be considered
when trying to gain market share.
Viagra
The main competitor of the product Cialis will be Viagra from Pfizer. It is the most widely known drug to
be used for erectile dysfunction. However, not all patients who are using Viagra are completely satisfied.
Only 25% of the patients who start using Viagra continue using it after a year. There are many complaints
and one of them is that it puts too much pressure on the couple to initiate sex, because the window of
opportunity is only 4 hours. Additionally, Viagra’s active ingredient targets many PDE enzymes and
causes side effects, such as blue-vision. The average price of a pill is 10$ for Viagra and in most cases it
has to be paid by the patients as it is not covered by other institutions. Over 85% of the people who use
Viagra were willing to try Cialis and over 77% of the Viagra dropouts were also willing to try Cialis. The
7/31/2019 Cialis Marketing Plan
http://slidepdf.com/reader/full/cialis-marketing-plan 3/5
market size of the Viagra dropouts is however much larger than the current approximate of 3 million
users. Considering the main reasons for people to cancel Viagra can be avoided with Cialis and made
known to the public through effective marketing, even more of the dropouts might be willing to try it.
Marketing Plan
Cialis should be positioned for beat strategy of differentiation as it offers much better effects than the
current market leader, Viagra. It does not have most of the side effects as it is focused on the PDE 5
enzyme and doesn’t affect others as much. Additionally, it has a much wider window of opportunity of
almost 36 hours, thus removing the pressure of having immediate sex. The sexual partner doesn’t need to
feel like she has to engage in immediate intercourse just because the drug was taken. It can be taken one
day and be used for the second one. Thus, it can even be taken discretely without the sexual partner’s
knowledge, nullifying the pressure effect. One study showed that 70% of the most important
characteristics are safety and efficacy, while only 10% is duration. However, considering the main
reasons of dissatisfaction with Viagra, duration might have a much higher percentage of importance. To
sum up, it is important to focus on proving the importance of duration and the clear superiority of Cialis
over both Viagra and Levitra in this respect, subsequently sending this message to both physicians and
patients. Additionally, it important to also show the fact that Cialis has a much shorter list of side effects.
As concerns, Levitra, it has chosen a niche strategy and it focuses on people with diabetes. Moreover, it
has only a weak influence in the US, where the strongest market for ED lies. It is thus not as important as
Viagra in terms of competition. GMSO would have to organize the market planning. Considering much
research is already done, it is important to focus on transmitting the message to the physicians and
potential patients. It should focus almost half its resources for gaining the trust of the physicians and just
as much for the patients. Considering it is following a beat strategy, the price should be around the same
price of Viagra or even higher. However, considering it is important to gain market share, many
promotions could be offered and also a discount for continued use of the product. Considering Pfizer has
the biggest share of the market and has a lot of resources, its response can be significant. It is important to
keep our marketing strategy as efficient and effective as possible, because the product is clearly a better
choice and it must be made known to the end-users. Levitra is also an important drug for the companies
involved, however it does not fix the main problem of Viagra, duration and thus it is not as big of a threat.
7/31/2019 Cialis Marketing Plan
http://slidepdf.com/reader/full/cialis-marketing-plan 4/5
Appendix
7/31/2019 Cialis Marketing Plan
http://slidepdf.com/reader/full/cialis-marketing-plan 5/5
BibliographyMorales A, G. C. (1998). Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile
dysfunction. International Journal of Impotence Research.
Opek, E. (2010, July 28). Product Team Cialis: Getting Ready to Market. Harvard Business School .
Wikipedia. (2012, April). Sildenafil . Retrieved from Wikipedia: http://en.wikipedia.org/wiki/Sildenafil